STOCK TITAN

UY Scuti flags going-concern doubt, $2.3M deficit

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

UY Scuti Acquisition Corp. reported net income of $90,535 for the three months ended September 30, 2026, as $302,729 of trust-account interest exceeded $212,194 of operating expenses. Six-month net income was $255,400, compared with $484,070 in the same 2025 period; the company has no operating revenue before a business combination.

At September 30, the Trust Account held $36,351,195, while cash outside it was $1,858. UY Scuti reported a $2,302,370 working-capital deficit and stated these conditions raise substantial doubt about its ability to continue as a going concern. The merger agreement for Isdera Group was amended to set its agreed net value at $920 million, down from $1 billion. A September 30 extension loan of $450,000 brought total extension deposits to $1,350,000 and extended the business-combination deadline to January 1, 2027.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 2 points

How the balance works

Positive

  • None.

Negative

  • Major pointGoing-concern doubt: $2,302,370 working-capital deficit at September 30.
  • Minor pointQuarterly net income: $90,535, versus $151,992 a year earlier.

Filing Explained

If the Isdera merger closes, share-based seller consideration and 4.7 million advisor shares increase the share count; convertible transaction loans could add more.

This 10-Q describes the amended Isdera merger agreement as a proposed transaction, not a completed one. At closing, Isdera shareholders are to receive newly issued PubCo ordinary shares based on an agreed net value of $920 million and a price of $10 per share; the transaction advisor is also due 4.7 million PubCo Class A shares.

If issued, these shares increase the share count and reduce existing holders’ percentage ownership, absent offsetting changes. Other transaction-related notes also provide for possible share issuance: as of September 30, 2026, $482,253 was outstanding under a sponsor note that may be converted, and the $450,000 Extension Note I is to convert at maturity. Both convert at $10 per unit, with each unit carrying one ordinary share and a right to receive one-fifth of a share. An October 22, 2026 note documents $900,000 borrowed from Isdera HK; a Xinghui note allows borrowing up to $200,000, with $135,154 outstanding when issued. Both notes may convert at $10 per unit, but those conversion rights terminate if the lender is or would become a Purchaser subsidiary at closing.

Quarterly net income $90,535 Three months ended September 30, 2026; $151,992 in the three months ended September 30, 2025
Six-month net income $255,400 Six months ended September 30, 2026; $484,070 in the six months ended September 30, 2025
Operating expenses $212,194 Three months ended September 30, 2026; $440,012 in the same 2025 period
Trust Account balance $36,351,195 As of September 30, 2026
Cash outside the Trust Account $1,858 As of September 30, 2026
Working-capital deficit $2,302,370 As of September 30, 2026
Isdera Group agreed net value $920,000,000 Agreed value under the merger agreement amended September 22, 2026; previously $1,000,000,000
Extension deposits $1,350,000 Aggregate deposited into the Trust Account for business-combination extensions as of September 30, 2026
going concern financial
"substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
ordinary shares subject to possible redemption financial
"Ordinary shares subject to possible redemption, 3,312,712 shares"
net tangible assets financial
"net tangible assets of at least $5,000,001"
Net tangible assets are what remains of a company’s physical, measurable assets (cash, buildings, equipment, inventory) after subtracting its debts and other obligations, excluding intangible items like goodwill, patents or brand value. For investors it provides a conservative snapshot of the company’s minimum real-world worth—like the resale value of all physical things after paying bills—and helps judge balance-sheet strength and downside risk.
two-class method technical
"presentation of earnings (loss) per redeemable share and earnings (loss) per non-redeemable share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much net income did UYSC report for the quarter ended September 30, 2026?

UY Scuti reported net income of $90,535 for the quarter ended September 30, 2026. Trust-account interest of $302,729 exceeded operating expenses of $212,194; net income in the year-earlier quarter was $151,992.

What is the revised UYSC merger valuation for Isdera Group?

The parties amended the merger agreement on September 22, 2026, setting Isdera Group’s agreed net value at $920,000,000, down from $1,000,000,000. The agreement provides for consideration to Isdera Group shareholders in newly issued Purchaser ordinary shares, determined by dividing the agreed net value by $10.00 per share.

What is UYSC’s business-combination deadline?

Shareholders approved an extension framework through April 1, 2027, with each three-month extension requiring a $450,000 deposit into the Trust Account. The September 30, 2026 deposit extended the deadline to January 1, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

 

 

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission file number: 001-42577

 

UY Scuti Acquisition Corp.

(Exact name of registrant as specified in its charter)

 

Cayman Islands   N/A
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

39 E. Broadway, Suite 603

New York, New York 10002

(Address of principal executive offices)

 

(412) 947-0514

(Registrant’s telephone number, including area code)

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Ordinary Share, $0.0001 par value, and one right   UYSCU   The Nasdaq Stock Market LLC
Ordinary Shares, $0.0001 par value   UYSC   The Nasdaq Stock Market LLC
Rights to receive one-fifth (1/5th) of one Ordinary Share   UYSCR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒   No ☐

 

As of November 12, 2026, assuming all units have been separated, the registrant had 5,221,060 ordinary shares, $0.0001 par value per share, issued and outstanding.

 

 

 

 

 

 

UY SCUTI ACQUISITION CORP.

 

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2026

 

TABLE OF CONTENTS

 

    Page
Part I. Financial Information   1
Item 1. Financial Statements   1
Unaudited Condensed Balance Sheets   1
Unaudited Condensed Statements of Operations and Comprehensive Income   2
Unaudited Condensed Statements of Changes in Shareholders’ Equity (Deficit)   3
Unaudited Condensed Statements of Cash Flows   4
Notes to the Unaudited Condensed Financial Statements (Unaudited)   5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   18
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk   26
Item 4. Controls and Procedures   26
     
Part II. Other Information   27
Item 1. Legal Proceedings   27
Item 1A. Risk Factors   27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   27
Item 3. Defaults Upon Senior Securities   28
Item 4. Mine Safety Disclosures   28
Item 5. Other Information   28
Item 6. Exhibits   28
     
Part III. Signatures   29

 

i

Table of Contents

 

Part I. Financial Information

 

Item 1. Financial Statements

 

UY SCUTI ACQUISITION CORP.

UNAUDITED CONDENSED BALANCE SHEETS

Currency expressed in United States Dollars (“US$”), except for number of shares

 

   As of 
  

September 30,
2026

   March 31,
2026
 
   (Unaudited)   (Audited) 
Assets        
Cash and cash equivalents  $1,858   $8,846 
Prepaid expenses   23,250    - 
Total Current Assets  $25,108   $8,846 
           
Non-current asset          
Cash held in Trust Account   36,351,195    60,147,604 
Total non-current Asset  $36,351,195   $60,147,604 
           
Total Assets  $36,376,303   $60,156,450 
           
Liabilities, Ordinary shares subject to possible redemption and Shareholders’ Deficit          
Current Liabilities          
Accrued expenses   111,823    177,544 
Promissory Note - related parties   932,253    763,401 
Due to third parties   1,028,355    - 
Due to a related party   255,047    120,000 
Total Current Liabilities  $2,327,478   $1,060,945 
           
Commitments and Contingencies – (see Note 7)          
           
Ordinary shares subject to possible redemption, 3,312,712 and 5,750,000 shares issued and outstanding at redemption value of $10.97 and $10.46 as of September 30, 2026 and March 31, 2026, respectively.   36,351,195    60,132,006 
           
Shareholders’ Deficit          
Preference shares, $0.0001 par value; 10,000,000 shares authorized; nil and nil shares issued and outstanding as of September 30, 2026 and March 31, 2026, respectively.
   -    - 
Ordinary shares, $0.0001 par value; 490,000,000 shares authorized; 1,908,348 and 1,908,348 shares issued and outstanding (excluding 3,312,712 shares subject to redemption) as of September 30, 2026 and March 31, 2026, respectively*.   191    191 
Additional paid-in capital   975,238    990,836 
Accumulated deficit   (3,277,799)   (2,027,528)
Total Shareholders’ Deficit   (2,302,370)   (1,036,501)
Total Liabilities, Ordinary shares subject to possible redemption and Shareholders’ Deficit  $36,376,303   $60,156,450 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

  

1

Table of Contents

 

UY SCUTI ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME

Currency expressed in United States Dollars (“US$”), except for number of shares

 

   For the
Three Months Ended
September 30,
   For the
Six Months Ended
September 30,
 
   2026   2025   2026   2025 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Operating expenses  $212,194   $440,012   $350,169   $674,465 
Loss from Operations  $(212,194)  $(440,012)  $(350,169)  $(674,465)
Other income:                    
Interest earned on cash held in Trust Account   302,729    592,004    605,569    1,158,535 
Income before income taxes   90,535    151,992    255,400    484,070 
Income tax expense   -    -    -    - 
Net income  $90,535   $151,992   $255,400   $484,070 
                     
Other comprehensive income  $-   $-   $-   $- 
Comprehensive income  $90,535   $151,992   $255,400   $484,070 
                     
Basic and diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares   1,908,348    1,908,348    1,908,348    1,906,669 
Basic and diluted net loss per ordinary share, non-redeemable ordinary shares  $(0.13)  $(0.24)  $(0.24)  $(0.46)
Basic and diluted weighted average ordinary shares outstanding, redeemable ordinary shares   3,312,712    5,750,000    3,393,062    5,720,963 
Basic and diluted net income per ordinary share, redeemable ordinary shares  $0.10   $0.11   $0.21   $0.24 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

  

2

Table of Contents

 

UY SCUTI ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ DEFICIT

Currency expressed in United States Dollars (“US$”), except for number of shares

 

FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2026

 

   Ordinary Shares   Additional
Paid-in
   Accumulated   Total
Shareholders’
 
   Shares   Amount   Capital   Deficit   Deficit 
Balance as of March 31, 2026   1,908,348   $191   $990,836   $(2,027,528)  $(1,036,501)
Accretion of carrying value to redemption value   -    -    (15,598)   -    (15,598)
Subsequent measurement of ordinary shares subject to redemption (additional funding for business combination extension)   -    -    -    (450,072)   (450,072)
Subsequent measurement of ordinary shares subject to redemption (interest and dividends earned on trust account)   -    -    -    (302,840)   (302,840)
Net income   -    -    -    164,865    164,865 
Balance as of June 30, 2026 (Unaudited)   1,908,348   $191   $975,238   $(2,615,575)  $(1,640,146)
Subsequent measurement of ordinary shares subject to redemption (interest and dividends earned on trust account)   -    -    -    (302,729)   (302,729)
Subsequent measurement of ordinary shares subject to redemption (additional funding for business combination extension)   -    -    -    (450,030)   (450,030)
Net income   -    -    -    90,535    90,535 
Balance as of September 30, 2026 (Unaudited)   1,908,348   $191   $975,238   $(3,277,799)  $(2,302,370)

 

FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2025 

 

           Additional   Retained
earnings
   Total
Shareholders’
 
   Ordinary Shares   Paid-in   (Accumulated   Equity 
   Shares   Amount   Capital   Deficit)   (Deficit) 
Balance as of March 31, 2025   1,437,500   $144   $24,856   $(163,268)  $(138,268)
Proceeds allocated to Public Rights   -    -    5,387,388    -    5,387,388 
Sale of private placement shares   240,848    24    2,408,456    -    2,408,480 
Issuance of representative shares   230,000    23    2,112,577    -    2,112,600 
Underwriters’ discount and other offering expenses   -    -    (3,264,646)   -    (3,264,646)
Accretion of ordinary share subject to redemption value   -    -    (1,970,381)   -    (1,970,381)
Net income   -    -    -    332,078    332,078 
Balance as of June 30, 2025 (Unaudited)   1,908,348   $191   $4,698,250   $168,810   $4,867,251 
Accretion of ordinary share subject to redemption value   -    -    (2,027,051)   -    (2,027,051)
Net income   -    -    -    151,992    151,992 
Balance as of September 30, 2025 (Unaudited)   1,908,348   $191   $2,671,199   $320,802   $2,992,192 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

Table of Contents

 

UY SCUTI ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

Currency expressed in United States Dollars (“US$”), except for number of shares

 

  

For the Six Months Ended

September 30,

 
   2026   2025 
   (Unaudited)   (Unaudited) 
Cash Flows from Operating Activities:        
Net income  $255,400   $484,070 
Adjustments to reconcile net cash used in operating activities:          
Operating cost paid by Sponsor   243,899    86,570 
Amortization of prepaid expenses   63,750    - 
Interest earned on cash held in Trust Account   (605,569)   (1,158,535)
Changes in operating assets and liabilities          
Prepaid expenses   (87,000)   (300,417)
Accrued expenses   (65,721)   (15,000)
Due to third parties   128,253    - 
Due to Sponsor   60,000    60,000 
Net cash used in operating activities   (6,988)   (843,312)
           
Cash Flows from Investing Activities:          
Cash deposited into Trust Account   (1,350,102)   (57,500,000)
Withdrawal of cash held in trust account for public shareholder redemptions   25,302,079    - 
Net cash generated by (used in) investing activities   23,951,977    (57,500,000)
           
Cash Flows from Financing Activities:          
Proceeds from promissory note - related party   450,000    - 
Proceeds from third parties   900,102    - 
Withdrawal of cash held in trust account for public shareholder redemptions   (25,302,079)   - 
Repayment of promissory note payable - related party   -    (337,584)
Proceeds from sale of public units through public offerings, net of underwriters’ discount   -    56,493,744 
Proceeds from ordinary shares issued in private placement   -    2,408,480 
Payment of deferred offering costs   -    (229,700)
Net cash (used in) generated by financing activities   (23,951,977)   58,334,940 
           
Net change in cash   (6,988)   (8,372)
Cash at beginning of the period   8,846    17,221 
Cash at end of the period  $1,858   $8,849 
           
Supplemental Disclosure of Non-cash Activities          
Representative shares issued and charged to offering costs  $-   $2,112,600 
Initial classification of ordinary shares subject to possible redemption  $-   $5,387,388 
Allocation of offering costs to ordinary shares subject to possible redemption  $-   $306,005 
Accretion and subsequent measurement of ordinary shares subject to redemption value  $(1,521,268)  $(3,997,432)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

  

4

Table of Contents

 

UY SCUTI ACQUISITION CORP.

NOTES TO THE UNAUDITED CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

 

Note 1 — ORGANIZATION AND BUSINESS DESCRIPTION

 

UY Scuti Acquisition Corp. (the “Company” or “UY Scuti”), is a blank check company incorporated under the laws of the Cayman Islands with limited liability on January 18, 2024. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of September 30, 2026, the Company had not commenced any operations. All activities through September 30, 2026 are related to the Company’s formation and the initial public offering (“IPO”) described below, and subsequent to the IPO, identifying a target company for a Business Combination, entering into the Merger Agreement (as defined below) with Isdera Group Limited, and taking actions in connection with the business combination contemplated by the Merger Agreement. The Company generated non-operating income in the form of dividend and/or interest income from the proceeds derived from the IPO and sale of Private Placement Units (as defined below). The Company has selected March 31 as its fiscal year end.

 

The Company’s sponsor is UY Scuti Investments Limited (the “Sponsor”), a British Virgin Islands company. The Company’s ability to commence operations was contingent upon obtaining adequate financial resources through the IPO (see Note 3) and a Private Placement (as defined below) to the Sponsor (see Note 4).

 

The registration statement for the Company’s IPO was declared effective on March 31, 2025. On April 1, 2025, the Company consummated its IPO of 5,000,000 units (the “Public Units”), which is described in Note 3. Each Public Unit consists of one ordinary share of the Company, par value US$0.0001 per share (“Ordinary Share”) and one right to receive one-fifth (1/5th) of one Ordinary Share upon the consummation of an initial business combination (“Right”). The Public Units were sold at an offering price of $10.00 per Public Unit, generating gross proceeds of $50,000,000.

 

Simultaneously with the closing of the IPO on April 1, 2025, the Company consummated the private placement (“Private Placement”) with UY Scuti Investments Limited, its Sponsor, of 227,500 units (the “Private Units”) at a price of $10.00 per Private Unit, generating total gross proceeds of $2,275,000, which is described in Note 4. The Company also issued to Maxim Group LLC, the representative of the underwriter, 200,000 ordinary shares (the “Representative Shares”) on the closing of the IPO.

  

In connection with the IPO, the underwriters were granted a 45-day option (the “Over-Allotment Option”) to purchase up to 750,000 additional units to cover over-allotments (the “Option Units”), if any. On April 7, 2025, the underwriter exercised the over-allotment option in part to purchase an additional 357,622 Option Units of the Company (the “Over-Allotment Option”) at an offering price of $10.00 per Option Unit of the Company, generating gross proceeds of $3,576,220 which was deposited into the Trust Account. In addition, on April 9, 2025, the underwriter exercised the remaining portion of the Over-Allotment Option to purchase an additional 392,378 Option Units of the Company at an offering price of $10.00 per Option Unit, for gross proceeds of $3,923,780, which amount was deposited into the Trust Account, which is described in Note 3.

 

Simultaneously with the issuance and sales of the Option Units, the Company completed a private placement sale of additional 13,348 units (the “Additional Private Units” and together with the Initial Private Units, collectively, the “Private Units”) to the Sponsor at a purchase price of $10.00 per Additional Private Unit, generating gross proceeds of $133,480, including the cancellation of $62,580 of indebtedness. In connection with the issuance and sales of the Option Units, the Company issued additional 30,000 Representative Shares to the Representative. The fair value of the Representative Shares accounted for as compensation under Accounting Standards Codification (“ASC”) 718, “Compensation – Stock Compensation” (“ASC 718”) is included in the offering costs.

 

As of April 9, 2025, an aggregate of $57,500,000 was deposited in the Trust Account established in connection with the IPO.

  

5

Table of Contents

 

Transaction costs associated with the IPO and exercise of Over-Allotment Option amounted to $3,570,651, consisting of $1,006,256 and $2,112,600 of underwriting commissions which were paid in cash and representative shares (230,000 ordinary shares) at the closing date of the IPO, respectively and $451,795 of other offering costs. At the IPO date, cash of $809,914 (which is net of funds used to repay the then outstanding balance of the Promissory Note described in Note 5) was held outside of the Trust Account (as defined below) and was available for working capital purposes

. 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a business combination successfully.

 

The Company’s initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding income taxes payable on the interest earned) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target sufficient for the post-transaction company not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.

 

Upon the closing of the IPO, management has agreed that $10.00 per Unit sold in the IPO, including a portion of the proceeds of the sale of the Private Units, will be held in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, with a maturity of 185 days or less, or in money market funds meeting certain conditions of Rule 2a-7 of the Investment Company Act of 1940 which invest only in direct U.S. government treasury obligations, as determined by the Company. The proceeds from the IPO held in the trust account will not be released from the trust account (1) to the Company, until the completion of the initial business combination, or (2) to public shareholders, until the earliest of: (a) the completion of the initial Business Combination, (b) the redemption of any ordinary shares sold as part of the units in the IPO (the “public shares”) properly submitted in connection with a shareholder vote to amend the Company’s second amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to provide holders of the Company’s ordinary shares the right to have their shares redeemed in connection with the Company’s initial business combination or to redeem 100% of the Company’s public shares if the Company does not complete the initial business combination within 12 months from the closing of the IPO or after giving effect to the amendment to the Company’s amended and restated memorandum and articles of association approved on March 31, 2026, up to 24 months from the closing of the IPO (an “Extension Period”) or (B) with respect to any other provision relating to the rights of holders of the Company’s ordinary shares, and (c) the redemption of the Company’s public shares if it has not consummated the business combination within 24 months from the closing of the IPO or during any Extension Period, subject to applicable law. Public shareholders who redeem their ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent completion of an initial business combination or liquidation if the Company has not consummated an initial business combination within 24 months from the closing of the IPO, with respect to such ordinary shares so redeemed. The proceeds deposited in the trust account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders.

 

The ordinary shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. After giving effect to the amendment to the Company’s amended and restated memorandum and articles of association approved on March 31, 2026, the Company will have only 24 months from the closing of the IPO, including the Extension Period to complete the initial Business Combination (the “Combination Period”). If the Company is unable to complete the initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company for working capital purposes or to pay the Company’s taxes, divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s rights, which will expire worthless if the Company fails to complete the Business Combination within the Combination Period.

 

6

Table of Contents

 

The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer.

  

The Company has determined not to consummate any Business Combination unless the Company has net tangible assets of at least $5,000,001 upon such consummation in order to avoid being subject to Rule 419 promulgated under the Securities Act. However, if the Company seeks to consummate an initial Business Combination with a target business that imposes any type of working capital closing condition or requires us to have a minimum amount of funds available from the Trust Account upon consummation of such initial Business Combination, its net tangible asset threshold may limit the Company’s ability to consummate such initial Business Combination (as the Company may be required to have a lesser number of shares redeemed) and may force the Company to seek third party financing which may not be available on terms acceptable to the Company or at all. As a result, the Company may not be able to consummate such an initial Business Combination and the Company may not be able to locate another suitable target within the applicable time period, if at all.

 

Business Combination Agreement

 

On July 18, 2025, the Company entered into an Agreement and Plan of Merger (the "Original Merger Agreement") with Isdera Group Limited, a Cayman Islands company (“Isdera Group”), a company that shall become the parent company of Xinghui Automotive Technology (Hainan) Co., Ltd, a company in the business of designing automobiles in the People’s Republic of China (“Xinghui Automotive Technology”), and Xinghui Automotive Technology’s principal shareholders for a business combination. The aggregate consideration to be paid to Isdera Group shareholders upon consummation of the transactions contemplated by the Original Merger Agreement is such number of newly issued Purchaser Ordinary Shares determined by dividing the net value of Isdera Group, which was agreed to be $1,000,000,000, by $10.00 per share. The Merger Agreement contemplated that (i) the Company would cause the incorporation of a Cayman Islands exempted company (such company to be the “Purchaser”) and (ii) Purchaser, upon incorporation, would form another Cayman Islands exempted company as a direct wholly-owned subsidiary of Purchaser (the “Merger Sub”). The parties contemplated that both the Purchaser and Merger Sub would become parties to the Merger Agreement by executing a joinder agreement. On September 22, 2026, the Company, Isdera Group, Purchaser, Merger Sub, and certain other necessary parties to the Original Merger Agreement entered into the Joinder Agreement that resulted in each of Purchaser and Merger Sub becoming parties to the Original Merger Agreement. Thereafter, on September 22, 2026, the Company, Isdera Group, Purchaser, Merger Sub and certain other parties to the Original Merger Agreement entered into the First Amendment to the Merger Agreement (the “First Amendment” and together with the Original Merger Agreement, the “Merger Agreement”). Pursuant to the First Amendment, the parties agreed to adjust the definition of Company Net Value as provided for in the Original Merger Agreement from $1,000,000,000 to $920,000,000 and to make a number of additional corresponding revisions to the Original Merger Agreement and its schedules to reflect the agreement among the parties to adjust the valuation of Isdera Group to $920,000,000.

 

Extraordinary General Meeting of Shareholders

 

On March 31, 2026, the Company held an extraordinary general meeting of its shareholders (the “Extraordinary General Meeting”) and approved a proposal to extend the time available for the Company to consummate its initial Business Combination. Pursuant to the terms of the Company’s Amended and Restated Memorandum and Articles of Association and amendment to the Investment Management Trust Agreement dated March 31, 2025 between the Company and Continental Stock Transfer & Company (the “Trust Agreement”) approved at the Extraordinary General Meeting, in order to extend the time available for the Company to consummate its initial Business Combination, its sponsor or its affiliates or designees must deposit an aggregate of $450,000 on or prior to the date of the applicable deadline, for each three-month extension.

 

In connection with the shareholder votes at the Extraordinary General Meeting, holders of 2,437,288 ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.38 per share. As a result, approximately $25,302,078 was removed from the Trust Account to pay such holders, and approximately $34,390,068 remained in the Trust Account. Following these redemptions, the Company had 5,221,060 ordinary shares, including 3,312,712 Public Shares, outstanding.

 

Extension Payments

 

Effective as of March 31, 2026, Sun Peisha, an individual and the designee of the Sponsor, loaned the Company the aggregate amount of $450,000, which sum was deposited into the Trust Account in order to extend the time that the Company has to consummate a business combination for the first three-month extension period. On April 25, 2026, the Company issued a note to the lender to evidence the loan (the “Extension Note I”). The Extension Note I bears no interest and provides that it shall repay the outstanding principal on the date on which it consummates the business combination. On such maturity date, the entire outstanding principal balance of the Extension Note I shall be converted into units of its securities at a conversion price of $10.00 per unit, with each unit consisting of one ordinary share and one right to receive one-fifth of one ordinary share.

 

On June 30, 2026, Isdera HK Limited (Isdera HK), an affiliate of Isdera Group, loaned the Company the aggregate amount of $450,000, which sum was deposited into the Trust Account in order to extend the time that the Company has to consummate a business combination for the second three-month extension period.

 

On September 30, 2026, Isdera HK Limited loaned the Company the aggregate amount of $450,000, which sum was deposited into the Trust Account in order to extend the time that the Company has to consummate a business combination for the three months to January 1, 2027.

 

As of September 30, 2026, an aggregate of $1,350,000 was deposited into the trust account of the Company for the benefit of its public shareholders in connection with a previously approved extension of the period the Company has to consummate its initial business combination.

 

7

Table of Contents

 

Going concern consideration

 

The Company had a working capital deficit of $2,302,370, shareholders’ deficit of $2,302,370 and an accumulated deficit of $3,277,799 as of September 30, 2026. The Company had negative cash flow from operating activities of $6,988 for the six months ended September 30, 2026. The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the date the financial statements are issued.

 

Subsequent to the consummation of the IPO, our liquidity requirements have been satisfied through the net proceeds from the IPO, the Private Placement, loans from our Sponsor pursuant to the Promissory Note II (defined below), and a loan from third parties as described below. We have incurred, and expect to continue to incur, significant professional fees and costs to maintain our status as a publicly traded company, as well as significant transaction costs in connection with pursuing the consummation of a Business Combination.

 

In order to fund working capital deficiencies and finance transaction costs in connection with a Business Combination, on September 12, 2025, the Company issued an unsecured promissory note (the “Promissory Note II”) in the principal amount of up to $1,000,000 to Sponsor. The Promissory Note II bears no interest and was initially repayable by the Company to the Sponsor in full on the earlier of: (i) March 31, 2026 or (ii) the date of consummation of the Business Combination (the “Maturity Date”). Effective as of March 31, 2026, the Company and Sponsor agreed to amend and restate the Promissory Note II to extend the maturity date thereof to be the earlier of: (i) March 31, 2027 or (ii) the date on which we consummate a business combination. The principal balance may be prepaid at any time. At any time on or prior to the Maturity Date, the Sponsor may elect to convert the outstanding principal balance of the Promissory Note into units of the Company’s securities at a conversion price equal to $10.00 per unit. Each unit consists of one ordinary share and one right to receive one-fifth of one ordinary share. As of September 30, 2026, the principal amount due and owing under the Promissory Note II was $482,253.

 

On October 22, 2026, the Company issued a promissory note to Xinghui Automotive Technology in the principal amount of up to $200,000 (the “Xinghui Note”), pursuant to which the Company may borrow funds in one or more installments, up to an aggregate principal amount of $200,000, to finance transaction costs reasonably related to the Company’s proposed business combination.

 

The Company initially had 12 months from the closing of the IPO or up to 18 months from the closing of the IPO to complete a business combination. On March 31, 2026, the Company held the Extraordinary General Meeting at which its shareholders approved a proposal to extend the date by which it must complete a business combination up to four times from April 1, 2026 to April 1, 2027, with each extension comprised of a three-month extension period, subject to the Sponsor (or its designee) depositing $450,000 into the Trust Account for each extension period. If the Company has not consummated an initial business combination by April 1, 2027, the outstanding Public Shares will be redeemed. There is a possibility that business combination might not happen within the prescribed period of time.

 

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of the IPO, the requirement that the Company cease all operations, redeem the public shares and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern within one year after the date that the unaudited financial statements are issued. The unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.

   

Note 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments consisting of normal recurring adjustments considered necessary for a fair presentation of the unaudited condensed financial statements, have been included. Interim results are not necessarily indicative of results that may be expected through March 31, 2027 or for any future periods. These unaudited condensed financial statements should be read in conjunction with the Company’s 2026 Annual Report on Form 10-K as filed with the SEC on July 14, 2026. 

 

8

Table of Contents

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make a comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

  

Use of Estimates

 

In preparing these unaudited condensed financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Operating Segments

 

The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the chief operating decision maker (“CODM”), which is the Chief Executive Officer and Chairman of the Board, in deciding how to allocate resources and assess performance. The Company’s CODM evaluates the Company’s financial information and resources and assesses the performance of these resources. The Company is not organized by market and is managed and operated as one business. A single management team that reports to the CODM comprehensively manages the entire business. Accordingly, the Company does not accumulate discrete financial information with respect to separate divisions and does not have separate operating or reportable segments. Since the Company operates in one operating segment, all required financial segment information can be found in the unaudited condensed financial statements.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has cash and cash equivalents of $1,858 and $8,846 as of September 30, 2026 and March 31, 2026, respectively. 

 

9

Table of Contents

 

Cash Held in Trust Account

 

As of September 30, 2026 and March 31, 2026, the Company had $36,351,195 and $60,147,604, respectively, in cash held in the Trust Account.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, in Hong Kong, which, at times, may exceed the Deposit Protection Scheme (the “DPS”) HK$500,000 (approximately $64,000). As of September 30, 2026 and March 31, 2026, the Company has cash and cash equivalents of $1,858 and $8,846, respectively, deposited at a financial institution in Hong Kong, which the Company’s management believes is of a high credit quality. Such Deposit Insurance Regulations would not be effective in providing complete protection for the Company’s accounts, as its aggregate deposits are higher than the coverage limit. No balances were in excess of the insured amounts as of September 30, 2026.

 

The Company has not experienced losses on such account and management believes the Company is not exposed to significant risks on such account.

  

Ordinary Shares Subject to Possible Redemption

 

All of the 5,750,000 ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation.

 

The Company accounted for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (ASC 480). Ordinary shares subject to mandatory redemption (if any) were classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) were classified as temporary equity. At all other times, ordinary shares were classified as stockholders’ equity. In accordance with ASC 480-10-S99, the Company classified the ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company.

 

Given that the 5,750,000 ordinary shares sold as part of the units in the IPO were issued with other freestanding instruments (i.e., rights), the initial carrying value of ordinary shares classified as temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes in redemption value as a deemed dividend and charges against retained earnings or, in the absence of retained earnings, by charges against additional paid-in capital, over an expected 12-month period, which is the initial period that the Company has to complete a Business Combination.

 

For the three and six months ended September 30, 2026, the Company recorded subsequent remeasurement of ordinary shares subject to possible redemption of $302,729 and $1,071,239, respectively.

 

As of September 30, 2026, the ordinary shares subject to possible redemption reflected in the condensed balance sheet are recorded in the following table:

 

Gross proceeds  $57,500,000 
Less:     
Proceeds allocated to public rights   (5,387,388)
Offering costs allocated to redeemable shares   (306,005)
Plus:     
Accretion of carrying value to redemption value   6,127,795 
Subsequent measurement of ordinary shares subject to possible redemption (interest earned and unrealized gain on trust account and additional funding for business combination extension)   2,197,604 
Ordinary shares subject to possible redemption as of March 31, 2026  $60,132,006 
Less:     
Public shareholder redemptions   (25,302,079)
Plus:     
Accretion of carrying value to redemption value   15,598 
Subsequent measurement of ordinary shares subject to possible redemption (interest earned and unrealized gain on trust account and additional funding for business combination extension)   1,505,670 
Ordinary shares subject to possible redemption as of September 30, 2026 (Unaudited)  $36,351,195 

  

10

Table of Contents

 

Earnings (Loss) Per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. The unaudited condensed statements of operations and comprehensive income (loss) include a presentation of earnings (loss) per redeemable share and earnings (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the shares subject to possible redemption was considered to be dividends paid to the public shareholders. For the three and six months ended September 30, 2026 did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

 

Earnings (loss) per share presented in the unaudited condensed statements of operations and comprehensive income and loss is based on the following:

 

  

For the
Three Months Ended

September 30,

 
   2026   2025 
   (Unaudited)   (Unaudited) 
Net income  $90,535   $151,992 
Less: Subsequent measurement and accretion of redeemable ordinary shares to redemption value   (752,758)   (2,027,051)
Net loss including accretion of redeemable ordinary shares to redemption value  $(662,223)  $(1,875,059)

 

  

For the
Six Months Ended

September 30,

 
   2026   2025 
   (Unaudited)   (Unaudited) 
Net income  $255,400   $484,070 
Less: Subsequent measurement and accretion of redeemable ordinary shares to redemption value   (1,521,268)   (3,997,432)
Net loss including accretion of redeemable ordinary shares to redemption value  $(1,265,868)  $(3,513,362)

 

 
   For the Three Months Ended
September 30,
 
   2026   2025 
   Redeemable
Ordinary
Share
  

Non- Redeemable

Ordinary
Share

   Redeemable
Ordinary
Share
   Non-Redeemable Ordinary
Share
 
   (Unaudited)   (Unaudited) 
Numerators:                
Allocation of net loss  $(420,174)  $(242,049)  $(1,407,822)  $(467,237)
Accretion of redeemable ordinary shares to redemption value   752,758    -    2,027,051    - 
Allocation of net income (loss)  $332,584   $(242,049)  $619,229   $(467,237)
                     
Denominators:                    
Weighted-average ordinary shares outstanding   3,312,712    1,908,348    5,750,000    1,908,348 
                     
Basic and diluted earnings (loss) per share  $0.10   $(0.13)  $0.11   $(0.24)

 

   For the Six Months Ended
September 30,
 
   2026   2025 
   Redeemable
Ordinary
Share
   Non- Redeemable
Ordinary
Share
   Redeemable
Ordinary
Share
   Non- Redeemable
Ordinary
Share
 
   (Unaudited)       (Unaudited) 
Numerators:                
Allocation of net loss  $(810,194)  $(455,674)  $(2,635,132)  $(878,230)
Accretion of redeemable ordinary shares to redemption value   1,521,268    -    3,997,432    - 
Allocation of net income (loss)  $711,074   $(455,674)  $1,362,300   $(878,230)
                     
Denominators:                    
Weighted-average ordinary shares outstanding   3,393,062    1,908,348    5,720,963    1,906,669 
                     
Basic and diluted earnings (loss) per share  $0.21   $(0.24)  $0.24   $(0.46)

 

11

Table of Contents

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the unaudited condensed financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements.

 

Fair Value of Financial Instruments

 

ASC Topic 820 “Fair Value Measurements and Disclosures” defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC Topic 820 establishes a fair value hierarchy for inputs, which represents the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyers and sellers would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

 

The fair value hierarchy is categorized into three levels based on the inputs as follows:

 

●Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

 

●Level 2 - Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.

 

●Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820 approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. The carrying amounts reported in the balance sheet for cash and cash equivalents, Cash held in Trust Account, accrued expenses, due to third parties, Promissory Note- related parties and due to a related party each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period between the origination of such instruments and their expected realization and their current market rate of interest.

  

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of the presented periods, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

  

September 30,
2026

   Quoted
Prices in
Active Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets                
Cash held in trust account  $36,351,195   $36,351,195   $     -   $        - 

 

12

Table of Contents

 

   March 31,
2026
   Quoted
Prices in
Active Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets                
Cash held in trust account  $60,147,604   $60,147,604   $       -   $       - 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Recent Accounting Standards

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires public business entities to provide greater disaggregation of expenses, including inventory purchases, employee compensation, depreciation, amortization, and depletion, and to disclose the total amount and annual definition of selling expenses. In January 2025, the FASB issued ASU 2025-01, which clarifies that all public business entities are required to apply ASU 2024-03 for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The guidance should be applied prospectively, with retrospective application permitted. The Company is currently evaluating the impact of adopting ASU 2024-03 on its financial statements.

 

In November 2024, the FASB issued ASU 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies whether certain settlements of convertible debt instruments should be accounted for as induced conversions. ASU 2024-04 is effective for all entities for annual reporting periods beginning after December 15, 2025, and interim periods within those annual reporting periods. Early adoption is permitted, and the amendments should be applied prospectively. The Company is currently evaluating the impact of adopting ASU 2024-04 on its financial statements.

 

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statement.

 

Note 3 — INITIAL PUBLIC OFFERING

 

On April 1, 2025, the Company sold 5,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one ordinary share, par value $0.0001 per share and one right (the “Public Right”). Each Public Right entitles the holder to purchase one-fifth (1/5) of one ordinary share upon the consummation of the Company’s initial Business Combination. The Company will not issue fractional shares. As a result, the holder must hold Public Rights in multiples of 5 in order to receive shares for all of their Public Rights upon closing of a Business Combination. The Company also granted the underwriters a 45-day option to purchase up to an additional 750,000 units to cover over-allotments, if any.

 

On April 7, 2025, the underwriter exercised the over-allotment option in part to purchase an additional 357,622 Option Units of the Company (the “Over-Allotment Option”) at an offering price of $10.00 per Option Unit of the Company, generating gross proceeds of $3,576,220 which was deposited into the Trust Account. In addition, on April 9, 2025, the underwriter exercised the remaining portion of the Over-Allotment Option to purchase an additional 392,378 Option Units of the Company at an offering price of $10.00 per Option Unit, for gross proceeds of $3,923,780, which amount was deposited into the Trust Account.

 

The holders of the Units became eligible to separately trade the ordinary shares and the Public Rights beginning on May 27, 2025.

 

Note 4 — PRIVATE PLACEMENT

 

Simultaneously with the closing of the IPO on April 1, 2025, the Sponsor purchased an aggregate of 227,500 Initial Private Placement Units at a price of $10.00 per Initial Private Placement Units for an aggregate purchase price of $2,275,000. Each Initial Private Placement Unit was identical to the Public Units sold in the IPO except for certain registration rights and transfer restrictions.

 

Simultaneously with the issuance and sales of the Option Units on April 7 and April 9, 2025, the Company completed the private placement sale of an additional 13,348 units to the Sponsor at a purchase price of $10.00 per Additional Private Unit. The Private Placement generated total proceeds of $2,408,480, including the cancellation of $337,580 of indebtedness.

 

13

Table of Contents

 

Note 5 — RELATED PARTY TRANSACTIONS

 

Founder Shares

 

Pursuant to the Securities Subscription Agreement dated August 2, 2024, the Sponsor agreed to purchase 1,725,000 ordinary shares (the “Founder Shares”) for an aggregate price of $25,000. Due to the reduction in the offering size, the Company and sponsor subsequently entered into the Amended Subscription Agreement pursuant to which the Sponsor agreed to surrender for no consideration, and the Company subsequently cancelled, 287,500 ordinary shares previously issued the Sponsor, such that the Sponsor then held 1,437,500 Founder Shares purchased for an aggregate price of $25,000, with a par value $0.0001.

  

As of March 31, 2025, there were 1,437,500 ordinary shares issued and outstanding, among which, up to 187,500 ordinary shares are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On April 7, 2025, the underwriter exercised the Over-Allotment Option in part to purchase an additional 357,622 Units of the Company. On April 7, 2025, the underwriter notified the Company of its exercise of the remaining portion of the Over-Allotment Option to purchase an additional 392,378 Units of the Company at an offering price of $10.00 per Unit. Upon the full exercise of the over-allotment option, all of the 187,500 Founder Shares were no longer be subject to forfeiture.

 

The Founder shares except as described below, are identical to the ordinary shares included in the units being sold in the IPO, and holders of Founder shares have the same shareholder rights as public shareholders, except that (a) the Founder shares are subject to certain transfer restrictions, as described in more detail below; (b) the Company’s initial shareholders have entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder shares in connection with the completion of the Company’s initial Business Combination, (ii) waive their redemption rights with respect to their Founder shares, private placement shares and public shares held by them in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we have not consummated our initial business combination within the timeframe set forth therein or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, and (iii) to waive their rights to liquidating distributions from the Trust Account with respect to their Founder shares and private placement shares if the Company fails to complete our initial business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if the Company extends the period of time to consummate a business combination) (although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete the Company’s initial business combination within the Combination Period) and (c) are entitled to certain registration rights to provide for the resale of such shares under the Securities Act. If the Company submits its initial Business Combination to its public shareholders for a vote, its founder has agreed (and its permitted transferees will agree) to vote their Founder shares, private shares and any public shares purchased during or after the IPO in favor of its initial Business Combination. The other members of the Company’s management team have entered into agreements similar to the one entered into by the Company’s Sponsor with respect to any public shares acquired by them in or after the IPO.

 

The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than our independent registered public accounting firm) for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party or prospective target business who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Company’s Sponsor will not be responsible to the extent of any liability for such third-party claims.

 

The initial shareholders have agreed, not to transfer, assign or sell 100% of its Founder Shares until the earlier of (x) six months after the date of the consummation of the Company’s initial business combination or (y) the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share surrenders, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (z) the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction after its initial Business Combination which results in all of its shareholders having the right to exchange their ordinary shares for cash, securities or other property.

  

14

Table of Contents

 

Related Party Loans

 

Promissory Note II

 

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor, the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes the initial Business Combination, it intends to repay such loaned amount at closing. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such working capital loans made by the Sponsor, the Company’s officers and directors, or the Company’s or their affiliates to the Company prior to or in connection with its initial Business Combination may be convertible into units, at a price of $10.00 per unit at the option of the lender, upon consummation of its initial Business Combination. The units would be identical to the Placement Units.

 

On September 12, 2025, the Company issued an unsecured promissory note (the “Promissory Note II”) in the principal amount of up to $1,000,000 to Sponsor. The Promissory Note II bears no interest and was initially repayable by the Company to the Sponsor in full on the earlier of: (i) March 31, 2026 or (ii) the date of consummation of the Business Combination (the “Maturity Date”). Effective as of March 31, 2026, the Company and Sponsor agreed to amend and restate the Promissory Note II to extend the Maturity Date to be the earlier of: (i) March 31, 2027 or (ii) the date on which we consummate a business combination. The principal balance may be prepaid at any time. At any time on or prior to the Maturity Date, the Sponsor may elect to convert the outstanding principal balance of the Promissory Note II into units of the Company’s securities at a conversion price equal to $10.00 per unit. Each unit consists of one ordinary share and one right to receive one-fifth of one ordinary share. As of September 30, 2026 and March 31, 2026, the principal amount due and owing under the Promissory Note II was $482,253 and $313,401, respectively.

 

Extension Note I

 

Effective as of March 31, 2026, Sun Peisha, an individual and the designee of the Sponsor, loaned the Company the aggregate amount of $450,000, which sum was deposited into the Trust Account in order to extend the time that the Company has to consummate a business combination for the first three-month extension period. On April 25, 2026, the Company issued a note to the lender to evidence the loan (the “Extension Note I”). The Extension Note I bears no interest and provides that it shall repay the outstanding principal on the date on which it consummates the business combination. On such maturity date, the entire outstanding principal balance of the Extension Note I shall be converted into units of its securities at a conversion price of $10.00 per unit, with each unit consisting of one ordinary share and one right to receive one-fifth of one ordinary share.

 

As of September 30, 2026 and March 31, 2026, the Company had outstanding borrowings under Extension Note I of $450,000 and $450,000, respectively.

 

Administrative Support Services

 

Commencing on the effective date of the registration statement of the IPO, the Company has agreed to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of its initial Business Combination or its liquidation, the Company will cease paying these monthly fees.

 

For the three and six months ended September 30, 2026, the Company has accrued $30,000 and $60,000 for the administrative support services provided by the Sponsor.

 

For the three and six months ended September 30, 2025, the Company has accrued $30,000 and $60,000, respectively, for the administrative support services provided by the Sponsor.

 

As of September 30, 2026 and March 31, 2026, the balance of amount due to the Sponsor for administrative support services were $180,000 and $120,000, respectively. 

 

Due to a related party

 

As of September 30, 2026 and March 31, 2026, the Company had a balance of $75,047 and nil, respectively, due to a related party, the sponsor, to cover the Company’s formation and operating costs.

 

Note 6 — DUE TO THIRD PARTIES

 

As of September 30, 2026 and March 31, 2026, the Company had a balance due of $900,102 and nil, respectively, to Isdera HK, an affiliate of Isdera Group. The balance was due on demand, non-interest bearing and unsecured. In connection with the loans from Isdera HK, on October 22, 2026, the Company issued an unsecured promissory note in the principal amount of $900,000 to Isdera HK to evidence these loans.

 

As of September 30, 2026 and March 31, 2026, the Company had a balance of $128,253 and nil, respectively, to Xinghui Automotive Technology (Hainan) Co., Ltd., an affiliate of Isdera Group. The balance was due on demand, non-interest bearing and unsecured. On October 22, 2026, the Company issued a promissory note to Xinghui Automotive Technology in the principal amount of up to $200,000 (the “Xinghui Note”), pursuant to which the Company may borrow funds in one or more installments, up to an aggregate principal amount of $200,000, to finance transaction costs reasonably related to the Company’s proposed business combination.

 

The Isdera HK Note and Xinghui Note are both unsecured, bear no interest and mature upon closing of the Business Combination. Upon maturity, the outstanding principal balances under each note may be converted into units of the Company’s securities at a conversion price of $10.00 per unit, with each unit consisting of one ordinary share of the Company and one right to receive one-fifth of one ordinary share of the Company. However, if the holder of the Isdera HK Note or the Xinghui Note is or would become a subsidiary of Purchaser upon the closing of the Company’s initial business combination, the right of such holder to convert the outstanding principal amount of such note shall terminate.

 

15

Table of Contents

 

Note 7 — COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of the Founder Shares and Private Placement Units (and their underlying securities) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the IPO, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

  

Underwriting Agreement

 

The Company granted Maxim, the representative of the underwriters, a 45-day option from the date of the Company’s IPO prospectus to purchase up to 750,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions.

 

The underwriters were entitled to a cash underwriting discount of 1.75% of the gross proceeds of the IPO, or $875,000 (or $1,006,250 if the over-allotment option was exercised in full). Additionally, the Company issued the underwriter 4% of the gross proceeds of the IPO as underwriting discounts and commissions in the form of Representative Shares at a price of $10.00 per ordinary share, which equalled 200,000 shares (or 230,000 shares if the underwriter’s overallotment option was exercised in full) upon the consummation of the IPO.

  

In connection with the closing of the IPO, the Company issued 200,000 Representative Shares to the underwriter. In connection with the issuance and sales of the Option Units, the Company issued an additional 30,000 Representative Shares to Maxim, the representative of the underwriters.

 

The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales in the IPO pursuant to FINRA Rule 5110I (1). Pursuant to FINRA Rule 5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the commencement of sales in the IPO, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the date of the commencement of sales in the IPO except to any underwriter and selected dealer participating in the IPO and their officers, partners, registered persons or affiliates.

 

Financial Advisor Agreement

 

We entered into an advisory agreement with Keltwin International Limited (the “Advisor”) dated June 23, 2025, which was subsequently amended on July 1, 2026 (as amended, the “Advisory Agreement”). Pursuant to the Advisory Agreement, we engaged the Advisor to provide us with consultancy services including assistance in valuing, structuring and negotiating the terms for a transaction and assistance in the preparation of its proxy statement, registration statement, and/or other documents related to a business combination transaction. In consideration of such services, the Advisor agreed to be paid in 4,700,000 PubCo Class A Ordinary Shares upon the closing of the business combination transaction. The shares issuable to the Advisor are subject to a six-month lock-up period commencing on the closing date of the business combination transaction. Further, the Advisor was granted registration rights pursuant to which the shares issuable to them will either be included in the registration statement filed with the SEC in connection with the closing of the business combination or in a registration statement to be filed within thirty (30) days following the closing of the business combination covering the resale of such shares.

 

Note 8 — SHAREHOLDERS’ EQUITY

 

Preference Share

 

The Company is authorized to issue 10,000,000 shares of preference share, $0.0001 par value, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2026 and March 31, 2026, there were no preference shares issued or outstanding.

  

Ordinary shares

 

The Company is authorized to issue 490,000,000 shares of ordinary share with $0.0001 par value.

 

Pursuant to the Securities Subscription Agreement dated August 2, 2024, the Sponsor agreed to purchase 1,725,000 Founder Shares for an aggregate price of $25,000. Due to the reduction in the offering size, the Company and sponsor subsequently entered into the Amended Subscription Agreement pursuant to which the Sponsor agreed to surrender for no consideration and the Company subsequently cancelled, 287,500 ordinary shares previously issued the Sponsor, such that the Sponsor then held 1,437,500 Founder Shares purchased for an aggregate price of $25,000, with a par value $0.0001.

 

As of September 30, 2026 and March 31, 2026, excluding shares subject to redemption, there were 1,908,348 ordinary shares issued and outstanding, including ordinary shares underlying Units that have not been separated as of such date.

 

16

Table of Contents

 

Rights

 

Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will receive one-fifth (1/5) of an ordinary share upon consummation of the initial Business Combination. In the event the Company will not be the surviving company upon completion of our initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-fifth (1/5) of a share underlying each right upon consummation of the Business Combination unless otherwise waived in the course of the Business Combination. No fractional shares will be issued upon exchange of rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman Law.

  

Note 9 — SEGMENT INFORMATION

 

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their unaudited condensed financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s CODM, or group, in deciding how to allocate resources and assess performance.

 

The Company’s CODM has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.

 

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as net income or loss. The net loss is the measure of segment profit (loss) most consistent with U.S. GAAP that is regularly reviewed by the CODM to allocate resources and assess financial performance. The Company does not have an operating income and therefore, it does not have any revenue. The Company will not generate any operating revenue until after the completion of the Business Combination, at the earliest. The Company’s significant expenses were formation and operating costs as detailed below. The measure of segment assets is reported on the balance sheet as total assets.

 

When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

 

  

September 30,

2026

  

March 31,

2026

 
   (Unaudited)   (Audited) 
Cash and cash equivalents  $1,858   $8,846 
Cash held in Trust Account  $36,351,195   $60,147,604 

 

   For the Three Months Ended
September 30
 
   2026   2025 
   (Unaudited)   (Unaudited) 
Operating expenses  $212,194   $440,012 
Interest earned on cash held in Trust Account  $302,729   $592,004 

 

   For the Six Months Ended
September 30
 
   2026   2025 
   (Unaudited)   (Unaudited) 
Operating expenses  $350,169   $674,465 
Interest earned on cash held in Trust Account  $605,569   $1,158,535 

 

The CODM reviews income earned on marketable securities held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.

 

Operating expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction within the business combination period. The CODM also reviews operating expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Operating expenses, as reported on the statements of operations and comprehensive income and loss, are the significant segment expenses provided to the CODM on a regular basis.

 

Note 10 — SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited financial statements were issued. Based on the review, management identified the following subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

Extension Payments and Working Capital Loan

 

In October 2026, the Company issued a promissory note payable to Isdera HK Limited in the aggregate principal amount of $900,000 to evidence the extension loans provided by Isdera HK Limited as of June 30, 2026 and September 30, 2026. In addition, in October 2026, the Company issued a separate note payable to Xinghui Automotive Technology (Hainan) Co., Ltd. in the aggregate principal amount of up to $200,000 to evidence a working capital loan.

 

17

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

References to the “Company,” “UY Scuti,” “our,” “us” or “we” refer to UY Scuti Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form 10-Q (this “Quarterly Report”). Certain information contained in the discussion and analysis set forth below includes forward- looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and variations thereof and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

We are a blank check company incorporated in the Cayman Islands and formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities.

 

We intend to effectuate our initial business combination using cash from the proceeds of the Initial Public Offering (the “IPO”) and the sale of the private placement units, and the proceeds of potential sales of our securities in connection with our initial business combination, debt or a combination of cash, stock and debt. We expect to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

 

Pursuant to our Amended and Restated Memorandum and Articles of Association, as amended, if we are unable to complete our initial business combination within the Combination Period of twelve (12) months from the consummation of our IPO, subject to our ability to extend such time period by up to twelve (12) months, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of amounts withdrawn to pay our income taxes), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities and those necessary to prepare for the initial public offering and subsequent to our initial public offering, identifying a target company for an initial business combination, entering into the Merger Agreement (as defined below) with Isdera Group Limited, and taking actions in connection with the business combination contemplated by the Merger Agreement. Following the initial public offering, we will not generate any operating revenue until after completion of our initial business combination. We generated non-operating income in the form of interest income on investments held in trust and cash. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting, and auditing compliance), as well as for due diligence expenses related to our initial business combination.

  

18

Table of Contents

 

For the three months ended September 30, 2026, we had a net income of $90,535, which consists of interest earned on cash held in the Trust Account of $302,729, offset by operating costs of $212,194.

 

For the six months ended September 30, 2026, we had net income of $255,400, which consisted of interest earned on cash held in the Trust Account of $605,569, partially offset by formation and operating costs of $350,169.

 

For the three months ended September 30, 2025, we had net income of $151,992, which consisted of interest earned on cash held in the Trust Account of $592,004, partially offset by formation and operating costs of $440,012.

 

For the six months ended September 30, 2025, we had net income of $484,070, which consisted of interest earned on cash held in the Trust Account of $1,158,535, partially offset by formation and operating costs of $674,465.

 

Recent Developments

 

Business Combination Agreement

 

On July 18, 2025, we entered into the Merger Agreement (“Original Merger Agreement”) with Isdera Group Limited, a Cayman Islands company (“Isdera Group”), a company that shall become the parent company of Xinghui Automotive Technology (Hainan) Co., Ltd, which is in the business of designing automobiles in the People’s Republic of China (“Xinghui Technology”), and Xinghui Technology’s Principal Shareholders for a business combination. The Original Merger Agreement contemplated that (i) UYSC shall cause the incorporation of a Cayman Islands exempted company (such company to be the “Purchaser”) and (ii) the Purchaser, upon incorporation, shall form another company in the Cayman Islands as an exempted company and a wholly-owned subsidiary of Purchaser (the “Merger Sub”) for the purposes of consummating the business combination transactions described in the Original Merger Agreement. The parties contemplated that both the Purchaser and Merger Sub would become parties to the Original Merger Agreement by executing a joinder agreement. Pursuant to the Original Merger Agreement, as amended, we will merge with and into the Purchaser, resulting in its shareholders becoming shareholders of the Purchaser and concurrently therewith, Merger Sub will merge with and into Isdera Group, with Isdera Group surviving the merger and resulting in the Purchaser acquiring 100% of the issued and outstanding equity securities of Isdera Group (the “Acquisition Merger”). Pursuant to the Original Merger Agreement, the aggregate consideration to be paid to Isdera Group Shareholders for the Acquisition Merger is such number of newly issued PubCo Ordinary Shares determined by dividing the net value of Isdera Group, which was agreed to be $1,000,000,000, by $10.00 per share. Concurrently with the execution of the Original Merger Agreement, a principal shareholder of Isdera Group entered into a support agreement with UYSC, pursuant to which such shareholder of Isdera Group agreed not to transfer its shares of Isdera Group and to vote in favor of the Business Combination, subject to the terms of such shareholder support agreement.

 

On September 22, 2026, the Company, Isdera Group, Purchaser, Merger Sub, and certain other necessary parties to the Original Merger Agreement entered into the Joinder Agreement that resulted in each of Purchaser and Merger Sub becoming parties to the Original Merger Agreement. Thereafter, on September 22, 2026, UYSC, Isdera Group, PubCo, Merger Sub and certain other parties to the Original Merger Agreement entered into the First Amendment to the Merger Agreement (the “First Amendment” and together with the Original Merger Agreement, the “Merger Agreement”). Pursuant to the First Amendment, the parties agreed to adjust the definition of Company Net Value as provided for in the Original Merger Agreement from $1,000,000,000 to $920,000,000 and to make a number of additional corresponding revisions to the Original Merger Agreement and its schedules to reflect the agreement among the parties to adjust the valuation of Isdera Group to $920,000,000.

 

Sponsor Loan

 

On September 12, 2025, we issued a new promissory note in the principal amount of up to $1,000,000 to Sponsor (the “Promissory Note II”). The Promissory Note II bears no interest and initially provided that we shall repay the principal balance on the earlier of: (i) March 31, 2026 or (ii) the date on which we consummate a business combination. The principal balance may be prepaid at any time. Once an amount is drawn down under the Note, it shall not be available for future drawdown requests even if prepaid. The Promissory Note II was subject to customary events of default, the occurrence of certain of which entitles the Sponsor to declare, by written notice, the unpaid principal balance thereon and all other sums payable with regard to the Promissory Note II becoming due and payable within five (5) business days. Further, at any time on or prior to the maturity date, the Sponsor may elect to convert the outstanding principal balance of the Promissory Note II into units of our securities at a conversion price equal to $10.00 per unit. Each unit consists of one ordinary share and one right to receive one-fifth of one ordinary share. The terms of the units are identical to the private placement units sold by us simultaneously with the closing of its initial public offering. Effective as of March 31, 2026, the Company and Sponsor agreed to amend and restate the Promissory Note II to extend the maturity date thereof to be the earlier of: (i) March 31, 2027 or (ii) the date on which we consummate a business combination.

 

2026 Extraordinary General Meeting

 

On March 31, 2026, we held the Extraordinary General Meeting. At the Extraordinary General Meeting, holders of our Ordinary Shares approved certain amendments to our Second Amended and Restated Memorandum and Articles of Association (the “Charter Amendment Proposal”) and an amendment to our Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (the “Trust Amendment Proposal”). In accordance with the Charter Amendment Proposal, we received the approval of our shareholders to amend our Amended and Restated Memorandum and Articles of Association to (i) extend the date by which we must complete a business combination up to four times from April 1, 2026 to April 1, 2027, with each extension comprised of a three-month extension period, provided that the Sponsor or its designees cause to be deposited into the Trust Account the amount provided for in the Trust Agreement and (ii) provide that we will not withdraw any amounts out of the interest from the Trust Account to pay dissolution expenses.

 

19

Table of Contents

 

In accordance with the Trust Amendment Proposal, our shareholders approved the amendment of our Investment Management Trust Agreement to extend the period of time within which we must complete a business combination from two times, each by an additional three-month period to October 1, 2026, to a total of four times, each by an additional three-month period to April 1, 2027 (each an “Extension Period”), provided that the Sponsor and/or its designees deposit $450,000 into the Trust Account for each Extension Period. The Trust Agreement was also amended to provide that (x) if the extension fee is not timely deposited into the Trust Account, we shall have a period of thirty (30) days to pay any applicable past due payment for the extension fee and if we fail to make any applicable past due payment during the cure period, then we shall promptly liquidate the Trust Account and the property in the Trust Account shall be distributed to the public shareholders and (y) we will not withdraw any amounts out of the interest from the Trust Account to pay dissolution expenses.

 

In connection with the Charter Amendment Proposal and Trust Amendment Proposal, we agreed that (i) if we extend the time period within which to consummate a business combination and contribute the revised extension fee to the Trust Account in connection with such election, we intend to file a Current Report on Form 8-K to disclose such event and (ii) if the shareholders approve the Charter Amendment Proposal and the Trust Amendment Proposal, we would not seek another shareholder vote to approve a further change to the terms and conditions concerning extending the time period within which to consummate a business combination

 

In connection with the shareholder votes at the Extraordinary General Meeting, holders of 2,437,288 Ordinary Shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.38 per share. As a result, approximately $25,302,078 was removed from the Trust Account to pay such holders and approximately $34,390,068 remained in the Trust Account. Following these redemptions, we had 5,221,060 Ordinary Shares, including 3,312,712 Public Shares, outstanding.

 

Extension and Working Capital Loans

 

Effective as of March 31, 2026, Sun Peisha, an individual and the designee of the Sponsor, loaned us the aggregate amount of $450,000, which sum was deposited into the Trust Account in order to extend the time that we have to consummate a Business Combination for the first three-month extension period. On April 25, 2026, we issued the Extension Note I to the lender to evidence the loan. The Extension Note I bears no interest and provides that we shall repay the outstanding principal on the date on which we consummate a business combination. On such maturity date, the entire outstanding principal balance of the Extension Note I shall be converted into units of our securities at a conversion price of $10.00 per unit, with each unit consisting of one Ordinary Share and one right to receive one-fifth of one Ordinary Share.

 

On June 30, 2026, we caused an additional amount of $450,000 to be deposited into the Trust Account in order to further extend the time that we have to consummate our initial business combination to October 1, 2026. The second extension payment was loaned to us by Isdera HK Limited, an affiliate of Isdera Group. 

 

On September 30, 2026, we caused an additional amount of $450,000 to be deposited into the Trust Account in order to further extend the time that we have to consummate our initial business combination to January 1, 2027. The extension payment was loaned to us by Isdera HK Limited, an affiliate of Isdera Group. In connection with the foregoing loans from Isdera HK, on October 22, 2026, the Company issued an unsecured promissory note in the principal amount of $900,000 to Isdera HK to evidence these loans (the “Isdera HK Note”).

 

On October 22, 2026, the Company issued a promissory note to Xinghui Automotive Technology in the principal amount of up to $200,000 (the “Xinghui Note”), pursuant to which the Company may borrow funds in one or more installments, up to an aggregate principal amount of $200,000, to finance transaction costs reasonably related to the Company’s proposed business combination. As of the date of issuance, the principal amount outstanding under the Xinghui Note was $135,154.

 

The Isdera HK Note and Xinghui Note are both unsecured, bear no interest and shall become due and payable on the date on which the Company consummates the business combination transaction contemplated by the Merger Agreement. Upon maturity, the outstanding principal balances of both the Isdera HK Note and Xinghui Note may be converted into units of the Company’s securities at a conversion price of $10.00 per unit, with each unit consisting of one ordinary share of the Company and one right to receive one-fifth of one ordinary share of the Company. However, pursuant to each of their respective terms, if the holder of the Isdera HK Note or the Xinghui Note is or would become a subsidiary of Purchaser upon the closing of the Company’s initial business combination, the right of such holder to convert the outstanding principal amount of such note shall terminate, and the outstanding principal amount thereof shall be settled or discharged at closing through (i) cash repayment or (ii) a legally effective intercompany set-off, or (iii) another intercompany settlement mechanism, as determined by the holder and the Company.

 

Liquidity and Capital Resources

 

As of September 30, 2026, we had $1,858 in cash and cash equivalents held outside of the Trust Account, a working capital deficit of $2,302,370 and a shareholders’ deficit of $2,302,370. As of March 31, 2026, we had $8,846 in cash and cash equivalents held outside of the Trust Account, a working capital deficit of $1,052,099 and a shareholders’ deficit of $1,036,501. For the six months ended September 30, 2026, we had a net income of $255,400, which consists of interest earned on cash held in the Trust Account of $605,569, offset by operating costs of $350,169. For the six months ended September 30, 2026, we had negative cash flow from operating activities of $6,988. For the fiscal year ended March 31, 2026, we had a negative cash flow from operating activities of $843,315.

 

Our liquidity needs prior to the consummation of the IPO had been satisfied through a payment from the Sponsor of $25,000 for the Founder Shares and the loan under an unsecured promissory note from the Sponsor of $500,000. In connection with the closing of our IPO, the approximately $337,584 drawn down under the unsecured promissory note was repaid in full.

  

On April 1, 2025, we consummated the initial closing of our IPO of 5,000,000 units (the “Units”), at $10.00 per Unit, generating gross proceeds of $50,000,000. In connection with the IPO, the underwriters were granted a 45-day option (the “Over-Allotment Option”) to purchase up to 750,000 additional units to cover over-allotments (the “Option Units”), if any. In two separate closings of the Over-Allotment Option on April 7, 2025 and April 9, 2025, we sold an additional 750,000 Option Units at a price of $10.00 per Option Unit and raised additional gross proceeds of $7,500,000.

 

Simultaneously with the closing of our IPO, including the full exercise of the Over-Allotment Option, we consummated the sale of 240,848 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor, generating total gross proceeds of $2,408,480, including the cancellation of $337,500 of indebtedness. Each Private Placement Unit consists of one ordinary share and one right to receive one-fifth (1/5th) of one ordinary share. The Private Placement was conducted as a non-public transaction and, as a transaction by an issuer not involving a public offering, is exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance upon Section 4(a)(2) of the Securities Act.

 

20

Table of Contents

 

Upon the closing of the IPO and the private placement, a total of $57,500,000 was placed in a trust account (the “Trust Account”) maintained by Continental Stock Transfer & Trust Company as a trustee and will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), and that invest only in direct U.S. government treasury obligations. Except for the withdrawal of interest earned on the amounts in the trust account to fund the Company’s taxes, if any, or upon the redemption by public shareholders of Ordinary Shares in connection with certain amendments to the Company’s amended and restated memorandum and articles of association, none of the funds held in the trust account will be released until the completion of the Company’s initial business combination or the redemption by the Company of 100% of the outstanding Ordinary Shares issued by the Company in the Initial Public Offering if the Company does not consummate an initial business combination within the Combination Period.

  

We intend to use substantially all of the net proceeds of the IPO and the private placement, including the funds held in the Trust Account, in connection with our initial business combination and to pay our expenses relating thereto. To the extent that our capital stock is used in whole or in part as consideration to effect our initial business combination, the remaining proceeds held in the Trust Account as well as any other net proceeds not expended will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay any operating expenses or finders’ fees which we had incurred prior to the completion of our initial business combination if the funds available to us outside of the Trust Account were insufficient to cover such expenses. 

 

We will use funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination. We also have ongoing professional and other costs to maintain our reporting, listing, compliance and administrative requirements of being a publicly traded company. In addition, we could use a portion of the funds not being placed in trust to pay commitment fees for financing, fees to consultants to assist us with our search for a target business or as a down payment or to fund a “no-shop” provision (a provision designed to keep target businesses from “shopping” around for transactions with other companies or investors on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to do so. If we entered into an agreement where we paid for the right to receive exclusivity from a target business, the amount that would be used as a down payment or to fund a “no-shop” provision would be determined based on the terms of the specific business combination and the amount of our available funds at the time. Our forfeiture of such funds (whether as a result of our breach or otherwise) could result in our not having sufficient funds to continue searching for, or conducting due diligence with respect to, prospective target businesses.

 

We have incurred and expect to continue to incur significant professional costs to remain a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination. In connection with our assessment of going concern considerations in accordance with Financial Accounting Standards Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has considered the Company's working capital deficiency and the requirement to complete a Business Combination within the Combination Period. We cannot assure that our plans to consummate an initial business combination will be successful. In addition, if we are unable to complete a Business Combination within the Combination Period, our board of directors would proceed to commence voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that our plans to consummate a Business Combination will be successful within the time period we have to complete our initial business combination. As a result, management has determined that this additional condition also raises substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Going concern consideration

 

As of September 30, 2026, we had $1,858 in cash and cash equivalents held outside of the Trust Account, a working capital deficit of $2,302,370 and a shareholders’ deficit of $2,302,370. For the six months ended September 30, 2026, we had a net income of $255,400, which consists of interest earned on cash held in the Trust Account of $605,569, offset by operating costs of $350,169. For the six months ended September 30, 2026, we had negative cash flow from operating activities of $6,988.

 

Subsequent to the consummation of the IPO, our liquidity requirements have been satisfied through the net proceeds from the IPO, the Private Placement, loans from our Sponsor pursuant to the Promissory Note II, and loans from third parties as described above under the caption “Extension and Working Capital Loans”. We have incurred, and expect to continue to incur, significant professional fees and costs to maintain our status as a publicly traded company, as well as significant transaction costs in connection with pursuing the consummation of a Business Combination.

 

21

Table of Contents

 

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, on September 12, 2025, we issued an unsecured promissory note (the “Promissory Note II”) in the principal amount of up to $1,000,000 to our Sponsor. The Promissory Note II bears no interest and after giving effect to the amendment to the Promissory Note II, it is repayable by us to the Sponsor in full on the earlier of (i) March 31, 2027 or (ii) the date of consummation of a Business Combination (the “Maturity Date”). The principal balance may be prepaid at any time. At any time on or prior to the Maturity Date, the Sponsor may elect to convert the outstanding principal balance of the Promissory Note II into units of our securities at a conversion price of $10.00 per unit. Each unit consists of one ordinary share and one right to receive one-fifth of one ordinary share. As of September 30, 2026, the principal amount due and owing under the Promissory Note II was $482,253.

 

Subsequently, on October 22, 2026, we issued the Xinghui Note to Xinghui Automotive Technology in the principal amount of up to $200,000, pursuant to which the Company may borrow funds in one or more installments, up to an aggregate principal amount of $200,000, to finance transaction costs reasonably related to the Company’s proposed business combination. As of the date of issuance, the principal amount outstanding under the Xinghui Note was $135,154. The Xinghui Note bears no interest and shall become due and payable on the date on which the Company consummates the business combination transaction contemplated by the Merger Agreement. As described above in greater detail, upon maturity, the outstanding principal balances of the Xinghui Note may be converted into units of the Company’s securities at a conversion price of $10.00 per unit, unless, however, the holder of the Xinghui Note is or would become a subsidiary of Purchaser upon the closing of the Company’s initial business combination.

 

Our Amended and Restated Memorandum and Articles of Association originally provided that we will have until 12 months from the closing of our IPO, or up to 18 months from the closing of the IPO, to consummate an initial business combination. Following the approval of the Charter Amendment Proposal and Trust Amendment Proposal at our Extraordinary General Meeting held on March 31, 2026, if we do not consummate an initial business combination by April 1, 2027, we will be required to redeem the public shares and thereafter liquidate and dissolve. Accordingly, there is a possibility that an initial business combination may not be completed within the Combination Period.

 

In connection with our assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern, management has determined that if we are unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of the IPO, the requirement that we cease all operations, redeem the public shares, and thereafter liquidate and dissolve raises substantial doubt about our ability to continue as a going concern within one year after the date the unaudited financial statements are issued. The unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.

  

The Company currently believes that it does not need additional capital to satisfy its liquidity needs beyond the net proceeds from the consummation of the IPO, the proceeds held outside of the Trust Account, and as discussed above, amounts available to it under the Promissory Note II and the Xinghui Note for paying existing accounts payable, identifying and evaluating prospective business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Initial Business Combination. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our public shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Our sponsor, an affiliate of our sponsor or our officers and directors may, but none of them is obligated to, loan us funds as may be required to fund our working capital requirements. If we complete our initial business combination, we will repay such loaned amounts out of the proceeds of the trust account released to us. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per unit. Such units would be identical to the private placement units issued to our sponsor. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor, an affiliate of our sponsor, our officers and directors, or persons associated with our business combination target, if any, as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. In addition, if we raise additional funds through equity or convertible debt issuances, our public shareholders may suffer significant dilution, and these securities could have rights that rank senior to our public shares. If we raise additional funds through the incurrence of indebtedness, such indebtedness would have rights that are senior to our equity securities and could contain covenants that restrict our operations.

 

Off-Balance Sheet Financing Arrangements

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

22

Table of Contents

 

Contractual Obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $10,000 for certain general and administrative services, including office space, utilities and administrative services, provided to the Company. We began incurring these fees on April 1, 2025 and will continue to incur these fees monthly until the earlier of the completion of a Business Combination or the Company’s liquidation.

  

Registration Rights

 

Pursuant to an agreement entered into on March 31, 2025, our initial shareholders are entitled to registration rights requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted Maxim, the representative of the underwriters, for a period of 45-days, the option to purchase up to 750,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions.

 

The underwriters were entitled to a cash underwriting discount of 1.75% of the gross proceeds of the IPO, or $875,000 (or $1,006,250 including the full exercise of the over-allotment option). Additionally, the Company issued the underwriter 4% of the gross proceeds of the IPO as underwriting discounts and commissions in the form of Representative Shares at a price of $10.00 per ordinary share, which equalled 200,000 shares (or 230,000 shares if the underwriter’s overallotment option is exercised in full) upon the consummation of the IPO.

 

In connection with the closing of the IPO, the Company issued 200,000 Representative Shares to the underwriter. In connection with the issuance and sales of the Option Units, the Company issued an additional 30,000 Representative Shares to Maxim, the representative of the underwriters.

 

Financial Advisor Agreement

 

We entered into an advisory agreement with Keltwin International Limited (the “Advisor”) dated June 23, 2025, which was subsequently amended on July 1, 2026 (as amended, the “Advisory Agreement”). Pursuant to the Advisory Agreement, we engaged the Advisor to provide us with consultancy services including assistance in valuing, structuring and negotiating the terms for a transaction and assistance in the preparation of its proxy statement, registration statement, and/or other documents related to a business combination transaction. In consideration of such services, the Advisor agreed to be paid in 4,700,000 PubCo Class A Ordinary Shares upon the closing of the business combination transaction. The shares issuable to the Advisor are subject to a six-month lock-up period commencing on the closing date of the business combination transaction. Further, the Advisor was granted registration rights pursuant to which the shares issuable to them will either be included in the registration statement filed with the SEC in connection with the closing of the business combination or in a registration statement to be filed within thirty (30) days following the closing of the business combination covering the resale of such shares.

 

Critical Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The accompanying unaudited condensed financial statements as of September 30, 2026 has been prepared in accordance with U.S. GAAP and the rules of the SEC.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

23

Table of Contents

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

  

Ordinary Shares Subject to Possible Redemption

 

All of the 5,750,000 ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation.

 

The Company accounted for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (ASC 480). Ordinary shares subject to mandatory redemption (if any) were classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) were classified as temporary equity. At all other times, ordinary shares were classified as stockholders’ equity. In accordance with ASC 480-10-S99, the Company classified the ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company.

 

Given that the 5,750,000 ordinary shares sold as part of the units in the IPO were issued with other freestanding instruments (i.e., rights), the initial carrying value of ordinary shares classified as temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes in redemption value as a deemed dividend and charges against retained earnings or, in the absence of retained earnings, by charges against additional paid-in capital, over an expected 12-month period, which is the initial period that the Company has to complete a Business Combination. 

 

Use of Estimates

 

In preparing these unaudited condensed financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.

  

24

Table of Contents

 

Earnings (Loss) Per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. The unaudited condensed statements of operations and comprehensive income and loss include a presentation of earnings (loss) per redeemable share and earnings (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the shares subject to possible redemption was considered to be dividends paid to the public shareholders. For the three and six months ended September 30, 2026 did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

 

Fair Value of Financial Instruments

 

ASC Topic 820 “Fair Value Measurements and Disclosures” defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC Topic 820 establishes a fair value hierarchy for inputs, which represents the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

 

The fair value hierarchy is categorized into three levels based on the inputs as follows:

 

  ● Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.
     
  ● Level 2 - Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.
     
  ● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820 approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. The carrying amounts reported in the balance sheet for cash and cash equivalents, marketable securities held in trust account, accounts payable and accrued expenses and due to related parties each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period between the origination of such instruments and their expected realization and their current market rate of interest.

 

Recent Accounting Standards

 

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statement.

  

25

Table of Contents

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not required for smaller reporting companies.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

Evaluation of Disclosure Controls and Procedures

 

Our management evaluated, with the participation of our current chief executive officer and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of the end of the quarter ended September 30, 2026, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of September 30, 2026, our disclosure controls and procedures were effective at the reasonable assurance level.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Inherent Limitations on Effectiveness of Internal Controls

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived financially literate and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

   

26

Table of Contents

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

The Company is not party to any legal proceedings as of the filing date of this Form 10-Q.

 

ITEM 1A. RISK FACTORS.

 

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026 filed with the SEC on July 14, 2026 and any additional filings made by the Company following such date. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Use of Proceeds

 

On August 2, 2024, our sponsor entered into a subscription agreement with us to purchase 1,725,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.01 per share. Due to the reduction in the offering size, we and our sponsor subsequently amended such securities subscription agreement, pursuant to which we subsequently cancelled 287,500 founder shares such that our sponsor now owns an aggregate of 1,437,500 founder shares for an aggregate purchase price of $25,000.

 

The registration statement for our initial public offering was declared effective by the Securities and Exchange Commission on March 31, 2025. We completed our initial public offering on April 1, 2025. In our initial public offering, we sold 5,750,000 units at an offering price of $10.00, including units sold in connection with the exercise of the Over-Allotment Option, generating gross proceeds of $57,500,000. Each Unit consisted of one ordinary share and one right. Each right entitles the holders thereof to receive one-fifth (1/5th) of one ordinary share upon the consummation of the initial business combination.

 

Simultaneously with the closing of the IPO, pursuant to the Private Placement Units Purchase Agreement by and between the Company and our sponsor, UY Scuti Investments Limited, the Company completed the private sale of an aggregate of  240,848 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $2,408,480.

 

Transaction costs related to our IPO amounted to $3,019,884, consisting of $875,000 of underwriting fees, $1,812,600 of the Representative Shares and $332,284 of other offering costs. A total of $57,500,000, from the proceeds of the IPO and the Private Placement, was placed in a U.S.-based trust account, established by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any of the Company’s public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it does not complete its initial business combination within the Combination Period, or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity, and (iii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within the Combination Period.

 

Net cash generated from the IPO and private placement units and held outside of the trust was used in operating activities was $792,706. As of September 30, 2026, the Company had a working capital deficit of $2,302,370.

 

Our management has broad discretion with respect to the specific application of the proceeds of the IPO and the Private Placement that are held out of the Trust Account, although substantially all the net proceeds are intended to be applied generally towards consummating a business combination and working capital. Since our IPO, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. We presently have no revenue and have had losses since inception from incurring formation and operating costs. We have relied upon the sale of our securities and loans from the Sponsor and other parties to fund our operations.

  

27

Table of Contents

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

During the quarter ended September 30, 2026, no director or officer adopted or terminated any (i) “Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K intending to satisfy the affirmative defense conditions of Rule 10b5–1(c) or (ii) “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(c) of Regulation S-K.

 

ITEM 6. EXHIBITS.

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

No.   Description of Exhibit
2.1†   First Amendment to Agreement and Plan of Merger, dated September 22, 2026 (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed on September 24, 2026).
2.2   Joinder Agreement, dated September 22, 2026 (incorporated by reference to Exhibit 2.2 to the Current Report on Form 8-K filed on September 24, 2026).
10.1   Promissory Note, dated October 22, 2026, in favor of Isdera HK Limited (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on October 23, 2026).
10.2   Promissory Note, dated October 22, 2026, in favor of Xinghui Automotive Technology (Hainan) Co., Ltd. (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on October 23, 2026).
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*   Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

 

* Filed herewith.
** Furnished.
† Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant hereby undertakes to furnish copies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission.

   

28

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  UY SCUTI ACQUISITION CORP.
     
Date: November 13, 2026   /s/ Qunxue Yin
  Name:   Qunxue Yin
  Title: Chief Executive Officer
(Principal Executive Officer)
     
Date: November 13, 2026   /s/ Jiawen Zhao
  Name: Jiawen Zhao
  Title: Interim Chief Financial Officer
(Principal Financial Officer)

  

29

 

00-0000000 0 0 0 0 0 0002036973 false 2027 Q2 --03-31 0002036973 2026-04-01 2026-09-30 0002036973 uysc:UnitsEachConsistingOfOneOrdinaryShare00001ParValueAndOneRightMember 2026-04-01 2026-09-30 0002036973 uysc:OrdinaryShares00001ParValueMember 2026-04-01 2026-09-30 0002036973 uysc:RightsToReceiveOnefifth15thOfOneOrdinaryShareMember 2026-04-01 2026-09-30 0002036973 2026-11-12 0002036973 2026-09-30 0002036973 2026-03-31 0002036973 2026-07-01 2026-09-30 0002036973 2025-07-01 2025-09-30 0002036973 2025-04-01 2025-09-30 0002036973 uysc:OrdinarySharesNotSubjectToPossibleRedemptionMember 2026-07-01 2026-09-30 0002036973 uysc:OrdinarySharesNotSubjectToPossibleRedemptionMember 2025-07-01 2025-09-30 0002036973 uysc:OrdinarySharesNotSubjectToPossibleRedemptionMember 2026-04-01 2026-09-30 0002036973 uysc:OrdinarySharesNotSubjectToPossibleRedemptionMember 2025-04-01 2025-09-30 0002036973 uysc:OrdinarySharesSubjectToPossibleRedemptionMember 2026-07-01 2026-09-30 0002036973 uysc:OrdinarySharesSubjectToPossibleRedemptionMember 2025-07-01 2025-09-30 0002036973 uysc:OrdinarySharesSubjectToPossibleRedemptionMember 2026-04-01 2026-09-30 0002036973 uysc:OrdinarySharesSubjectToPossibleRedemptionMember 2025-04-01 2025-09-30 0002036973 us-gaap:CommonStockMember 2026-03-31 0002036973 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002036973 us-gaap:RetainedEarningsMember 2026-03-31 0002036973 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002036973 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0002036973 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0002036973 2026-04-01 2026-06-30 0002036973 us-gaap:CommonStockMember 2026-06-30 0002036973 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0002036973 us-gaap:RetainedEarningsMember 2026-06-30 0002036973 2026-06-30 0002036973 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0002036973 us-gaap:CommonStockMember 2026-09-30 0002036973 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0002036973 us-gaap:RetainedEarningsMember 2026-09-30 0002036973 us-gaap:CommonStockMember 2025-03-31 0002036973 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002036973 us-gaap:RetainedEarningsMember 2025-03-31 0002036973 2025-03-31 0002036973 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0002036973 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0002036973 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0002036973 2025-04-01 2025-06-30 0002036973 us-gaap:CommonStockMember 2025-06-30 0002036973 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0002036973 us-gaap:RetainedEarningsMember 2025-06-30 0002036973 2025-06-30 0002036973 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0002036973 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0002036973 us-gaap:CommonStockMember 2025-09-30 0002036973 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0002036973 us-gaap:RetainedEarningsMember 2025-09-30 0002036973 2025-09-30 0002036973 us-gaap:IPOMember 2025-04-01 2025-04-01 0002036973 us-gaap:IPOMember 2025-04-01 0002036973 uysc:SponsorMember 2025-04-01 2025-04-01 0002036973 uysc:SponsorMember 2025-04-01 0002036973 us-gaap:OverAllotmentOptionMember 2025-04-01 2025-04-01 0002036973 us-gaap:OverAllotmentOptionMember 2025-04-07 2025-04-07 0002036973 us-gaap:OverAllotmentOptionMember 2025-04-07 0002036973 us-gaap:OverAllotmentOptionMember 2025-04-09 2025-04-09 0002036973 us-gaap:OverAllotmentOptionMember 2025-04-09 0002036973 uysc:AdditionalPrivateUnitsMember 2025-04-01 2025-04-01 0002036973 uysc:AdditionalPrivateUnitsMember 2025-04-01 0002036973 2025-04-01 2025-04-01 0002036973 us-gaap:IPOMember 2025-04-09 0002036973 us-gaap:IPOMember 2026-09-30 0002036973 uysc:IsderaIncMember 2025-07-18 2025-07-18 0002036973 uysc:IsderaIncMember 2025-07-18 0002036973 srt:MaximumMember 2026-09-22 2026-09-22 0002036973 srt:MinimumMember 2026-09-22 2026-09-22 0002036973 uysc:IsderaGroupMember 2026-09-22 2026-09-22 0002036973 uysc:ExtensionNoteMember 2026-04-25 0002036973 uysc:IsderaHKMember 2026-06-30 0002036973 uysc:IsderaHKMember 2026-09-30 0002036973 uysc:PublicShareholdersMember 2026-09-30 0002036973 uysc:SponsorMember 2025-09-12 2025-09-12 0002036973 uysc:PromissoryNoteIIMember 2026-09-30 0002036973 uysc:XinghuiAutomotiveTechnologyMember us-gaap:SubsequentEventMember 2026-10-22 2026-10-22 0002036973 uysc:XinghuiAutomotiveTechnologyMember us-gaap:SubsequentEventMember 2026-10-22 0002036973 uysc:SponsorMember 2026-09-30 0002036973 country:HK 2026-09-30 0002036973 country:HK 2026-03-31 0002036973 uysc:OrdinarySharesMember 2026-04-01 2026-09-30 0002036973 2025-04-01 2026-03-31 0002036973 us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002036973 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002036973 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002036973 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002036973 us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0002036973 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0002036973 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0002036973 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0002036973 us-gaap:PrivatePlacementMember 2025-04-01 2025-04-01 0002036973 us-gaap:PrivatePlacementMember 2025-04-01 0002036973 uysc:AdditionalPrivateUnitsMember 2025-04-07 2025-04-07 0002036973 uysc:AdditionalPrivateUnitsMember 2025-04-09 2025-04-09 0002036973 uysc:AdditionalPrivateUnitsMember 2025-04-07 0002036973 uysc:AdditionalPrivateUnitsMember 2025-04-09 0002036973 us-gaap:PrivatePlacementMember 2026-04-01 2026-09-30 0002036973 uysc:UYScutiInvestmentsLimitedMember uysc:FounderShareMember 2024-08-02 2024-08-02 0002036973 uysc:UYScutiInvestmentsLimitedMember uysc:FounderShareMember 2024-08-02 0002036973 srt:MaximumMember uysc:UYScutiInvestmentsLimitedMember uysc:FounderShareMember 2026-03-31 0002036973 2025-04-07 2025-04-07 0002036973 uysc:UYScutiInvestmentsLimitedMember uysc:FounderShareMember 2026-09-30 0002036973 uysc:UYScutiInvestmentsLimitedMember uysc:FounderShareMember 2026-04-01 2026-09-30 0002036973 srt:MaximumMember uysc:UYScutiInvestmentsLimitedMember uysc:FounderShareMember 2026-09-30 0002036973 srt:MaximumMember uysc:WorkingCapitalLoansMember us-gaap:CommonStockMember 2026-04-01 2026-09-30 0002036973 uysc:PromissoryNoteTwoMember 2025-09-12 0002036973 uysc:PromissoryNoteTwoMember 2025-09-12 2025-09-12 0002036973 uysc:PromissoryNoteTwoMember 2026-09-30 0002036973 uysc:PromissoryNoteTwoMember 2026-03-31 0002036973 uysc:SponsorMember 2026-03-31 0002036973 uysc:ExtensionNoteMember 2025-04-01 2025-06-30 0002036973 uysc:AdministrativeSupportServicesMember us-gaap:RelatedPartyMember 2026-04-01 2026-09-30 0002036973 uysc:SponsorMember 2026-09-30 0002036973 uysc:SponsorMember 2026-03-31 0002036973 uysc:IsderaGroupLimitedMember 2026-09-30 0002036973 uysc:IsderaGroupLimitedMember 2026-03-31 0002036973 uysc:IsderaGroupLimitedMember us-gaap:SubsequentEventMember 2026-10-22 0002036973 uysc:XinghuiAutomotiveTechnologyMember 2026-09-30 0002036973 uysc:XinghuiAutomotiveTechnologyMember 2026-03-31 0002036973 uysc:XinghuiAutomotiveTechnologyMember us-gaap:SubsequentEventMember 2026-10-22 0002036973 srt:MaximumMember us-gaap:OverAllotmentOptionMember 2026-09-30 0002036973 us-gaap:OverAllotmentOptionMember 2026-09-30 0002036973 uysc:RepresentativeSharesMember 2026-09-30 0002036973 srt:MaximumMember uysc:RepresentativeSharesMember 2026-09-30 0002036973 us-gaap:CommonClassAMember uysc:FinancialAdvisorAgreementMember 2025-06-23 2025-06-23 0002036973 uysc:FinancialAdvisorAgreementMember 2025-06-23 2025-06-23 0002036973 uysc:IsderaHKLimitedMember us-gaap:SubsequentEventMember 2026-10-31 0002036973 uysc:XinghuiAutomotiveTechnologyHainanCoLtdMember us-gaap:SubsequentEventMember 2026-10-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure uysc:segment iso4217:HKD

Keep reading